Form D · Other Health Care

Sora Neuroscience, Inc.

Minneapolis, MN · CIK 0001882130

Offering snapshot reported Nov 20, 2024 · SEC filing

Reported sold
$1.43M
Offering amount: $2M
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 16, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$714K$1.43MOct 31, 2023: $737,500.00Oct 31, 2023Nov 20, 2024: $1,427,500.00Nov 20, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$737,500 → $1,427,500
  • Reported investors17 → 20

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 20, 2024Amendment$1,427,500$690,000vs Oct 31, 202320SEC filing
Oct 31, 2023Initial$737,500No comparison17SEC filing
Sep 9, 2021Initial$1,980,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-496211

Source: Form D, filed Nov 20, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tara Butler Director
Eric Leuthardt Director
Daniel Marcus Director
Stephen R. Schaefer Director, Executive, Promoter
Ann Senn Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
4406 Beard Avenue South Suite Ul2
Minneapolis, MN, 55410